Pricing Log in Create free account

Aura Biosciences, Inc. (AURA) vs Pharming Group N.V. Sponsored ADR (PHAR)

Aura Biosciences, Inc. and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. Aura Biosciences, Inc. and Pharming Group N.V. Sponsored ADR are of similar size ($681.6M and $657.5M). Aura Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 62.4×. Pharming Group N.V. Sponsored ADR has the higher net margin (2.55% vs 0.00%) and the higher return on invested capital (5.50% vs 0.00%). Across the 15 metrics below, Pharming Group N.V. Sponsored ADR leads on 11 and Aura Biosciences, Inc. on 4.

Valuation

Metric AURA PHAR Biotechnology median
P/E n/m 62.40 8.50
P/S n/m 1.36 9.71
P/B 1.84 1.85 2.13
Price to free cash flow n/m 14.53 20.82
EV/EBITDA n/m 14.36 0.64
EV/Sales n/m 1.20 9.21
Earnings yield (28.69%) 1.60% (33.15%)
Free cash flow yield (17.86%) 6.88% (25.50%)

Profitability

Metric AURA PHAR Biotechnology median
Gross margin 0.00% 86.54% 65.16%
Operating margin 0.00% 5.04% 0.00%
Net margin 0.00% 2.55% 0.00%
Free cash flow margin 0.00% 9.38% 0.00%
Return on equity (53.49%) 3.67% (56.36%)
Return on assets (47.42%) 2.05% (48.04%)
Return on invested capital 0.00% 5.50% 0.00%

Growth

Metric AURA PHAR Biotechnology median
Revenue growth (TTM) — 7.85% 6.02%
EPS growth (last fiscal year) (0.57%) 125.00% 30.26%
Revenue growth, 5-year CAGR — 12.13% 9.41%
Net income growth, 5-year CAGR 0.00% (40.35%) 0.00%

Health

Metric AURA PHAR Biotechnology median
Debt to equity 0.00 0.36 0.00
Current ratio 16.82 3.01 4.72
Net debt to EBITDA 1.29 (2.21) 0.96

Dividend

Metric AURA PHAR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AURA PHAR Biotechnology median
Market cap 657.49m 681.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack